Yahoo Web Search

Search results

  1. Jun 18, 2024 · About Us. Who We Are. We are an innovative global healthcare company. Read more. Our Science. We turn the impossible into possible. Read more. Your Health. We chase the miracles of science to improve people’s lives. Read more.

    • Careers

      At Sanofi, you have a chance to create your own...

    • Investor Relations

      To join the Sanofi front desk, Please contact the Global...

    • Our Company

      Our fifth ‘brand film’ brings to life our purpose over the...

    • Science & Innovation

      Sanofi at VivaTech . Read the article. June 11, 2024....

    • Media

      You are a journalist and have a question about Sanofi,...

    • Your Health

      Vaccines are essential to public health. Ours help protect a...

    • Technology Platforms

      Our incredibly talented, creative scientists dig into a rich...

  2. Jun 18, 2024 · sanofi-aventis Philippines Inc. | Sanofi Pasteur Inc. 21st & 22nd Floors, One World Place Corporate Offices, 32nd St., Bonifacio Global City, Taguig City. For any concerns related to adverse events and product safety, please contact us at: Email: PV.Philippines@sanofi.com | Phone: +(632) 8859 5555

  3. Jun 21, 2024 · View the latest press releases from Sanofi global pharmaceutical and healthcare company.

  4. Jun 21, 2024 · Sanofi and Biovac have announced a partnership to establish the first African-based manufacturing capabilities for inactivated polio vaccines (IPV), marking a significant step towards regional vaccine self-sufficiency.

  5. Jun 18, 2024 · Sanofi is offering Belharra Therapeutics up to $700 million in biobucks for a tow out to surf the waves of small molecule drug discovery in immunology. The deal includes $40 million upfront and...

  6. 15 hours ago · This week, Eli Lilly won a long-awaited FDA approval for its Alzheimer's disease (AD) drug, donanemab, to be sold under the brand name Kisunla. Sanofi and partner Regeneron’s blockbuster drug ...

  7. Jun 16, 2024 · This is Sanofis attempt at capturing significant market share with a product that shares the mechanism of action but is significantly behind the market leader – Johnson & Johnson’s Darzalex.